Navigation Links
B. Braun To Sponsor Workshop and Platinum Showcase at AVA

BETHLEHEM, Pa., Sept. 3, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) will exhibit and host a Pre-Meeting Workshop and Platinum Showcase presentation at the 28th Association for Vascular Access (AVA) Annual Scientific Meeting in National Harbor, Maryland, September 7th-10th.

B.Braun, along with Analogic Corporation, is supporting a Pre-Meeting Workshop titled, "Ultrasound Guided Upper Extremity Simulation Workshop," on Saturday, September 6th from 1:00 – 5:00 p.m. at the Gaylord National Resort & Convention Center. Dr. Robert B. Dawson, DNP, MSA, APRN, ACNP-BC, CPUI, VA-BC, Vascular Access Consultant, PICC Academy and Nancy L. Moureau, BSN, CRNI, CPUI, VA-BC, President & CEO, PICC Excellence, Inc. will present. The Right Triangle Method will be featured, as well as the 45/50 rule for ultrasound peripheral catheter insertion to ensure optimal procedure success. This skills lab will reinforce both in plane and out of plane access for peripheral veins of the mid-forearm and upper arm.

Dr. Dawson will also be a featured presenter during the Platinum Showcase sessions. Dr. Dawson's session presentation, "Maximizing Peripheral Access Success: Featuring Clinical Application of Evidence using a Practice Framework," will provide a comprehensive overview on how to implement peripheral vascular access for the least risk to the patient to help achieve optimal outcomes. The presentation will take place on Monday, September 8th, 2014 from 3:30 – 4:30 p.m. at the Gaylord National Resort & Convention Center Potomac Room 3-4. B.Braun is also a proud sponsor of AVA foundation's annual fund raiser Connect the Dots, which supports education and research.

"Catheter-related bloodstream infections, needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major issues facing all healthcare professionals," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun. "We are committed to combating these issues by providing a robust portfolio of safety-engineered IV therapy devices that offer patient protection against infection and optimum safety for clinicians in the workplace," added Sutton.

Dr. Dawson will be the featured expert at B.Braun's booth where he will demonstrate his 45/50 rule for ultrasound peripheral vascular access on Monday, September 8th (1:15 – 2:15 p.m.), Tuesday, September 9th (12:15 – 1:15 p.m.), and Wednesday, September 10th (12:30 – 1:30 p.m.). In addition, B.Braun will demonstrate the following safety-engineered IV therapy devices at booth (#110) during AVA. 

  • Introcan Safety® IV Catheter, which is designed with innovative passive-safety features to help eliminate accidental needlestick injury - effortlessly. From insertion to catheter deployment to needle removal, clinicians are protected by a truly passive safety device that is activated automatically - no extra steps required and cannot be bypassed.
  • Introcan Safety® 3 Closed IV Catheter, B.Braun's latest innovation, which takes the same preferred passive safety-engineered needlestick protection found in Introcan Safety and adds additional protection from blood exposure. For safety and convenience, the Introcan Safety 3's unique multi-access blood control septum minimizes blood exposure during needle removal and each time the catheter hub is accessed.
  • InVision-Plus® Neutral IV Connector, the latest addition to the B.Braun needleless connector portfolio through an exclusive U.S. distribution agreement with RyMed Technologies, LLC, provides a 10-point standard of features. B.Braun's portfolio of needleless connectors, including the CARESITE® Luer Access Device, offers a safe way to access IV lines through innovative features designed to help reduce catheter occlusions while protecting healthcare workers from accidental needlestick injuries.

To learn more about B. Braun's activities at AVA, please visit

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit


SOURCE B. Braun Medical Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Joins National Health Organization Supporting Environmental Practices
2. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
3. B. Braun Launches New Patient Website
4. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
5. B. Braun Reveals Customer Satisfaction Survey
6. B. Braun Committed To Improving Patient Safety
7. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
8. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
9. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
10. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
11. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
Post Your Comments:
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):